For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/dare-to-move-beyond-symptom-improvement-schizophrenia-9781

Summary
Schizophrenia is a chronic and debilitating mental illness that significantly affects not only the health, well-being, and functioning of patients but also their surrounding environment. Promoting resilience is essential for enhancing health as well as treating mental health issues. A fresh perspective on schizophrenia emphasizes early intervention, symptom enhancement, relapse prevention, functional advancement, and quality of life improvement. The importance of personalized care to improve functional outcomes for individuals living with the condition gain insights into the DARE approach:

1. Detection – The importance of early detection and intervention in reducing the burden of schizophrenia and increasing recovery chances.
2. Adherence – Shared decision-making for optimal medication choice, focusing on balancing efficacy and minimizing adverse effects that can lead to nonadherence (e.g., sedation, weight gain).
3. Recovery – Functional recovery, quality of life, and achieving personal life goals as key outcomes in treatment.
4. Engagement – Supporting patients in leading purposeful and meaningful lives.

In this PsychTalk podcast/webcast episode, Dr. Gregory Mattingly and Dr. Vladimir Maletic discuss the DARE approach and how shifting the goals of schizophrenia treatment toward not just response and remission but full recovery and resilience, underscore a holistic approach to mental health. 

Learning Objectives
At the conclusion of this activity, participants should be better able to:

• Evaluate the latest advancements in functional domains for schizophrenia treatment.
• Discuss personalized treatment to improve functional outcomes for individuals living with schizophrenia.

This activity is accredited for CME/CE Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which does not include hours of pharmacology).

For additional information about the accreditation of this program, please contact NACE at [email protected].

Summary of Individual Disclosures
Please review faculty and planner disclosures here.
Disclosure of Commercial Support
This educational activity is not commercially funded.

Please visit http://naceonline.com to engage in more live and on demand CME/CE content.